Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...

"We found that [GLP-1 drug use] did increase ... tumors including medullary thyroid cancer in a dose- and treatment duration-dependent manner. This prompted all labels of GLP-1 agents to include ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Blueprint Medicines' fourth-quarter earnings and sales miss estimates. Shares of the company decline following the ...

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out of foods and drugs.

Exelixis beats on Q4 earnings and sales as lead drug Cabometyx maintains momentum. The company reiterates its guidance for 2025.

Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...

"Red dye" Google searches are at an all-time high after the US Food and Drug Administration (FDA) banned the ingredient earlier this month.

With rumours about celebrities using semaglutide drugs like Ozempic for quick weight loss the question remains Are these anti-diabetic medications truly the ‘miracle drugs’ theyre claimed to be We ask ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

The FDA banned Red Dye No. 3. The additive is found in over 9,000 U.S. products. Here’s how to avoid it, and what to reach for instead.